Overview

Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity

Status:
Recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
This study will address whether cannabis affects antiretroviral therapy (ART) drug concentrations, mood, and thinking. The project will have two phases. Phase 1 is an observational study, in which 120 people will be assessed to evaluate the effects of chronic cannabis use on ART drug concentrations, mood, and thinking. In Phase 2, the study will administer cannabis (or placebo) to 40 people to examine its acute effects on ART drug concentrations.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Diego
Collaborator:
Center for Medicinal Cannabis Research